Rituximab shows lasting benefits for rare skin disease
NCT ID NCT03790293
First seen Feb 06, 2026 · Last updated May 20, 2026 · Updated 11 times
Summary
This study followed 80 adults with pemphigus, a rare autoimmune blistering skin disease, who had previously received rituximab in the Ritux 3 trial. Researchers tracked long-term side effects and how many patients stayed in remission over several years. The goal was to understand how well rituximab controls the disease long-term and whether it leads to lasting immune changes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTOIMMUNE DISEASES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Ah-Hp Cochin
Paris, 75006, France
-
Ap-Hm La Timone
Marseille, 13385, France
-
Ap-Hp Avicenne
Bobigny, 93000, France
-
Ap-Hp Bichat
Paris, 75018, France
-
Ap-Hp Cochin
Paris, 75014, France
-
Ap-Hp Henri Mondor
Créteil, 94010, France
-
Ap-Hp Saint-Louis
Paris, 75010, France
-
Ch Le Mans
Le Mans, 72037, France
-
Chru Lille
Lille, 59000, France
-
Chu Angers
Angers, 49100, France
-
Chu Bordeaux
Bordeaux, 33076, France
-
Chu Brest
Brest, 29200, France
-
Chu Clermont-Ferrand
Clermont-Ferrand, 63100, France
-
Chu Dijon
Dijon, 21000, France
-
Chu Limoges
Limoges, 87000, France
-
Chu Montpellier
Montpellier, 34090, France
-
Chu Nantes
Nantes, 44000, France
-
Chu Reims
Reims, 51092, France
-
Chu Rennes
Rennes, 35000, France
-
Chu Rouen
Rouen, 76031, France
-
Chu Saint-Etienne
Saint-Etienne, 42270, France
-
Chu Toulouse
Toulouse, 31059, France
-
Chu Tours
Tours, 37000, France
-
Hcl Ch Lyon Sud
Lyon, 69310, France
-
Hcl Edouard Herriot
Lyon, 69003, France
Conditions
Explore the condition pages connected to this study.